Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-045934
Filing Date
2025-05-08
Accepted
2025-05-08 09:05:23
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm2514445d1_424b5.htm 424B5 292561
2 GRAPHIC image_004.jpg GRAPHIC 3032
3 GRAPHIC image_005.jpg GRAPHIC 21649
4 GRAPHIC image_006.jpg GRAPHIC 3143
  Complete submission text file 0001104659-25-045934.txt   332653
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-283722 | Film No.: 25924146
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)